microFAST Dx

microFAST Dx is a Durham, North Carolina-based biotechnology company specializing in rapid diagnostics. We develop upstream sample collection and processing technologies, specifically the RapiSep device, to enable decentralized diagnostics. Our innovative approach allows for self-blood tests at home and at the point of care (POC), expanding accessibility to rapid blood tests in the over-the-counter (OTC) and direct-to-consumer (DTC) markets.

We empower in vitro diagnostics (IVD) developers with a plasma separation device that simplifies sample preparation and accelerates the workflow. RapiSep is a supportive and adjunct assay technology upstream to testing, helping our partners dominate the growing self-test market for health and wellness monitoring, chronic disease management, and acute infection testing.

RapiSeped plasma maintains the integrity of a wide range of biomolecules, including proteins, DNA, and RNA, making it suitable for diverse diagnostic applications. We are dedicated to making rapid blood testing more accessible and convenient for consumers and healthcare professionals alike.